BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23116345)

  • 21. Contraceptive failure with the Mirena intrauterine system.
    Puzey M
    S Afr Med J; 2006 Apr; 96(4):310. PubMed ID: 16670802
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypersensitivity to Mirena--a rare complication.
    Pereira A; Coker A
    J Obstet Gynaecol; 2003 Jan; 23(1):81. PubMed ID: 12647710
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ectopic pregnancy in women who use intrauterine contraceptive devices].
    Curcić A; Orelj M; Novakov A; Stojilković-Mikić T; Kapamadzija A
    Med Pregl; 1997; 50(5-6):212-4. PubMed ID: 9297053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progestasert IUD and ectopic pregnancy.
    FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):37. PubMed ID: 720792
    [No Abstract]   [Full Text] [Related]  

  • 25. Ectopic pregnancy following emergency contraception with ethinyloestradiol-levonorgestrel: a case report.
    Matsushita H; Takayanagi T; Ikarashi H
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):184-6. PubMed ID: 17559018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy during the use of levonorgestrel intrauterine system.
    Backman T; Rauramo I; Huhtala S; Koskenvuo M
    Am J Obstet Gynecol; 2004 Jan; 190(1):50-4. PubMed ID: 14749634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian pregnancy in a patient with a levonorgestrel intrauterine system in situ.
    Kazal O; Ali AA
    Int J Gynaecol Obstet; 2012 Apr; 117(1):82-3. PubMed ID: 22239756
    [No Abstract]   [Full Text] [Related]  

  • 28. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial.
    Nelson A; Apter D; Hauck B; Schmelter T; Rybowski S; Rosen K; Gemzell-Danielsson K
    Obstet Gynecol; 2013 Dec; 122(6):1205-13. PubMed ID: 24240244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Progestasert and ectopic pregnancy.
    Br Med J; 1978 Jan; 1(6106):178-9. PubMed ID: 563762
    [No Abstract]   [Full Text] [Related]  

  • 30. The new LNG-releasing IUS: a new opportunity to reduce the burden of unintended pregnancy.
    Cristobal I; Neyro JL; Lete I
    Eur J Obstet Gynecol Reprod Biol; 2015 Jul; 190():58-64. PubMed ID: 25988513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ectopic pregnancy in the levonorgestrel releasing intrauterinesystem (LNG-IUS) user: atypical presentation.
    Abu JI; Wandless GM; Emembolu JO
    J Obstet Gynaecol; 2002 Sep; 22(5):567-8. PubMed ID: 12521443
    [No Abstract]   [Full Text] [Related]  

  • 32. Pseudo-decidual reaction to Mirena coil in a cervical smear: a potential diagnostic pitfall for false-positive cervical cytology.
    Hughes C; Woods J; Turner L; Gibbons D
    Cytopathology; 2005 Oct; 16(5):268-9. PubMed ID: 16181320
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine perforation and laparoscopic retrieval of a levonorgestrel intrauterine system (Mirena).
    Selo-Ojeme DO; Ekong ME; Welch CC
    J Obstet Gynaecol; 2003 Jul; 23(4):445-6. PubMed ID: 12881099
    [No Abstract]   [Full Text] [Related]  

  • 35. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception.
    Sivin I
    Obstet Gynecol; 1991 Aug; 78(2):291-8. PubMed ID: 2067778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Painful pelvic joints induced by a levonorgestrel-releasing intrauterine system.
    Fotoohi AK; Melin AS
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1142-3. PubMed ID: 21058450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.
    Eisenberg DL; Schreiber CA; Turok DK; Teal SB; Westhoff CL; Creinin MD;
    Contraception; 2015 Jul; 92(1):10-6. PubMed ID: 25934164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New Zealand.
    Harrison-Woolrych M; Zhou L; Coulter D
    N Z Med J; 2003 Aug; 116(1179):U538. PubMed ID: 14513085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mirena intrauterine system in the treatment of menstrual disorders: a survey of UK patients' experience, acceptability and satisfaction.
    Robinson R; China S; Bunkheila A; Powell M
    J Obstet Gynaecol; 2008 Oct; 28(7):728-31. PubMed ID: 19065370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.